loss
gastrointestin
gi
mucos
barrier
function
describ
leaki
gut
lay
term
age
invertebr
anim
leaki
gi
mucosa
allow
greater
transloc
microbi
antigen
microbi
transloc
mt
intestin
wall
portal
circul
incit
inflamm
local
mt
potenti
import
drive
metabol
health
evid
link
bacteri
endotoxemia
accumul
ectop
import
driver
insulin
although
intestin
leaki
occur
advanc
age
across
multipl
speci
recent
addit
document
import
mediat
lifespan
least
trend
microbiom
age
anim
model
peopl
consist
clinic
studi
repeatedli
demonstr
geograph
dietari
medic
effect
microbiom
make
gener
age
difficult
studi
evalu
fecal
microbiom
repres
catchal
approach
estim
colon
content
may
repres
locationspecif
microbiom
microbiom
close
associ
mucos
surfac
may
differ
may
small
subpopul
gener
microbiom
captur
gross
fecal
differ
may
attribut
effect
intestin
epitheli
cell
constantli
interact
microbiom
mucosa
contribut
host
defens
sever
mechan
immun
compet
close
relat
mucos
barrier
well
appreci
human
nonhuman
primat
elderli
experi
current
approv
therapeut
strategi
target
immunosenesc
specif
mt
indic
age
although
prebiot
probiot
commonli
use
counter
strategi
agerel
increas
leaki
difficult
assess
human
clinic
trial
set
age
diet
environment
factor
peopl
typic
chang
concomitantli
current
seri
studi
aim
survey
structur
function
chang
gut
age
use
relev
nonhuman
primat
model
confound
medic
dietari
hypothes
gi
barrier
defect
observ
older
may
improv
oral
dose
serum
bovin
immunoglobulin
sbi
clinic
util
nonabsorb
dietari
protein
product
consist
multipl
immunoglobulin
class
larg
pool
bovin
donor
thu
captur
immunoglobulin
type
gener
wide
rang
pathogen
immunoglobulin
enabl
direct
bind
pathogen
toxin
wherea
fc
region
protein
interact
immun
cell
support
intestin
homeostasi
reduc
inflammatori
stimuli
believ
predomin
effect
enhanc
intestin
barrier
integr
rather
endotoxin
bind
reduc
report
herein
agerel
leaki
gut
occur
age
western
diet
challeng
augment
leaki
lead
exagger
declin
health
data
suggest
adequ
colon
physic
barrier
element
innat
immun
respons
mt
present
old
monkey
thu
may
surpris
addit
oral
immunoglobulin
therapi
effect
revers
leaki
gut
improv
health
microbiom
profil
similar
across
age
consid
major
driver
loss
mucos
barrier
function
agerel
adapt
immunosenesc
investig
mechan
target
improv
gut
function
older
popul
subject
health
characterist
shown
supplementari
tabl
old
monkey
good
health
weight
redistribut
lead
higher
waist
circumfer
howev
valu
within
normal
nonobes
rang
speci
specif
chow
consumpt
assess
separ
cohort
agematch
young
n
old
monkey
n
monkey
sourc
vervet
coloni
show
signific
differ
daili
intak
vs
gday
p
mt
rate
old
monkey
significantli
elev
portal
vein
endotoxin
level
direct
measur
transloc
gramneg
bacteri
product
distribut
indic
higher
amount
blood
drain
gut
travel
liver
fig
accordingli
produc
liver
result
endotoxin
exposur
nearli
fivefold
higher
old
monkey
fig
p
endotoxin
level
differ
young
old
monkey
cohort
vs
p
histostructur
colon
differ
age
tabl
innat
immun
respons
measur
circul
secretori
iga
antimicrobi
peptid
greater
old
monkey
respect
p
consist
respons
leakier
gut
fig
b
mucos
sampl
old
monkey
higher
dna
content
fig
microbi
abund
mucos
surfac
trend
higher
old
monkey
fig
c
averag
bacteri
dna
sequenc
depth
amplif
higher
older
monkey
greater
consist
greater
bacteri
load
mucos
scrape
seen
qpcr
none
measur
perfect
indic
total
bacteri
number
togeth
support
hypothesi
higher
load
age
colon
mucosa
goblet
cell
produc
protect
mucu
physic
separ
bacteria
cell
gut
barrier
invers
relationship
bacteri
abund
goblet
cell
also
observ
fig
differ
age
group
amount
mucu
detect
within
goblet
cell
colon
tabl
microbiom
profil
across
sampl
site
significantli
differ
young
old
monkey
expect
base
consist
diet
prior
evalu
coloni
fig
supplementari
tabl
divers
microbiom
profil
differ
sampl
locat
mucosa
significantli
less
divers
fece
colon
lumen
content
phylum
level
p
p
respect
posthoc
tukey
honest
signific
differ
test
supplementari
fig
similarli
statist
signific
associ
rel
abund
individu
taxa
numer
age
age
group
monkey
fals
discov
rate
baselin
data
anim
includ
studi
shown
supplementari
tabl
six
young
old
monkey
transit
western
diet
supplementari
tabl
week
addit
old
monkey
stay
chow
diet
baselin
assess
control
chang
time
end
diet
challeng
old
monkey
exhibit
significantli
elev
liver
enzym
plasma
cholesterol
glucos
valu
wherea
young
monkey
consum
western
diet
old
monkey
remain
chow
unaffect
fig
healthi
old
monkey
went
normal
impair
fast
glucos
valu
mgdl
fast
glucos
five
old
monkey
avail
reevalu
alt
valu
week
return
healthi
chow
diet
notabl
alt
remain
significantli
elev
anim
supplementari
fig
indic
old
monkey
less
resili
nutrit
stress
diet
challeng
individu
suscept
persist
hepat
cholesterol
increas
young
old
monkey
consum
western
diet
doubl
valu
baselin
old
monkey
p
compar
nomin
chang
young
monkey
p
fig
mt
marker
measur
western
dietf
monkey
increas
old
monkey
young
monkey
valu
chang
significantli
respons
diet
challeng
supplementari
tabl
measur
microbiom
prior
diet
studi
shown
intervent
long
enough
enabl
detect
stabl
chang
fecal
profil
number
old
monkey
n
given
placebo
gday
sbi
daili
ad
g
daili
food
allot
week
crossov
studi
week
washout
treatment
period
complianc
monkey
oral
consum
sbi
dose
verifi
direct
observ
dose
consumpt
chang
food
intak
fecal
characterist
observ
sbi
effect
tabl
chang
health
relat
paramet
week
dose
mt
marker
remain
high
hepat
metabol
marker
studi
facilit
attempt
isol
agerel
factor
environment
influenc
primat
gi
system
confirm
healthi
age
associ
larg
structur
chang
colon
discuss
across
model
clinic
rather
function
deficit
permeabl
gi
barrier
posit
agerel
increas
gi
permeabl
leaki
gut
may
link
greater
number
resid
bacteria
mucos
surfac
main
function
compet
intestin
mucos
barrier
regul
bacteri
number
type
resid
surfac
clearanc
pathogen
detect
submucos
site
reticuloendotheli
tissu
seros
side
gut
bacteri
clearanc
mechan
could
overwhelm
compromis
immun
defici
occur
normal
mt
health
improv
antibiotictr
germfre
age
rodent
support
overgrowth
bacteria
mucosa
mechan
agerel
barrier
observ
high
mt
burden
old
monkey
prime
deterior
metabol
liver
biomark
respons
diet
challeng
underscor
need
attent
diet
qualiti
age
relat
frailti
health
also
test
intervent
sbi
known
reduc
endotoxemia
found
provid
benefit
age
monkey
young
healthi
host
mt
occur
low
rate
howev
immun
defens
remov
bacteria
effect
process
immun
cell
mucos
lamina
propria
deliveri
bacteria
via
drain
lymph
region
lymph
age
mice
lower
abil
present
antigen
gi
mucos
surfac
facilit
excess
infiltr
bacteria
bacteri
product
mucosa
young
gi
tissu
lead
deregul
intestin
immun
respons
result
develop
gastrointestin
deregul
effect
may
greater
howev
immunosenesc
gi
tissu
older
anim
captiv
monkey
undergo
agerel
immunosenesc
much
like
describ
human
chang
character
shift
immun
profil
includ
loss
cell
accompani
shift
toward
memori
phenotyp
cell
loss
cell
repertoir
divers
greater
system
result
show
innat
immun
respons
measur
iga
circul
higher
although
biomark
specif
gutderiv
antigen
demonstr
upregul
accord
endotoxem
howev
studi
evalu
circul
level
defensin
protein
valu
biomark
yet
fulli
understood
defensin
sole
produc
paneth
cell
circulatori
chang
may
specif
gut
patholog
howev
increas
support
greater
pathogen
load
seen
age
risk
develop
metabol
diseas
liver
damag
increas
age
men
women
nonhuman
consequ
western
diet
high
calori
high
fat
high
simpl
sugar
consumpt
liver
monkey
model
shown
age
diet
independ
predict
sever
liver
thu
ration
advanc
age
plu
western
dietari
challeng
would
interact
gi
barrier
function
synergist
drive
worsen
health
outcom
leakier
gut
age
monkey
preexist
exagger
respons
dietari
challeng
consist
concept
inflammag
observ
metabol
diseas
specif
subclin
hepat
greater
older
biomark
alreadi
indic
high
mt
rate
exist
diet
challeng
exacerb
biomark
respons
consist
recent
clinic
trial
compar
respons
young
old
peopl
shortterm
diet
oral
immunoglobulin
use
extens
veterinari
medicin
decad
aid
intestin
support
prevent
endotoxemia
reduc
inflamm
thu
hope
therapi
would
effect
reduc
endotoxemia
inflamm
seen
sbi
clinic
indic
hivassoci
enteropathi
like
age
associ
immun
defici
howev
even
hiv
patient
sbi
intervent
similar
conduct
consist
improv
gi
barrier
posit
trial
gener
limit
diarrheal
diseas
result
present
herein
monkey
studi
indic
immunoglobulin
respons
present
respons
leaki
gut
addit
immunoglobulin
improv
barrier
function
consist
failur
immunoglobulin
approach
failur
new
pharmacotherapi
endotoxin
bind
capac
sevelam
exampl
reduc
mt
thu
suggest
strategi
revers
immunosenesc
inhibitor
mammalian
target
rapamycin
longterm
calor
restrict
effect
enhanc
human
nonhuman
primat
cell
function
potenti
focus
analysi
simplifi
microbiom
outcom
divers
mucos
abund
variabl
increasingli
advoc
measur
compar
across
found
divers
less
mucos
site
expect
mucosa
favor
surviv
microb
known
colon
outer
intestin
mucu
layer
presenc
abund
protect
mucu
result
select
pressur
reduc
bacteri
divers
featur
prevent
metabol
diseas
develop
anim
observ
relationship
goblet
cell
produc
mucu
bacteri
gene
count
mucosa
support
concept
limit
current
studi
includ
enrol
femal
subject
rel
small
number
individu
demonstr
increas
mt
two
separ
cohort
age
monkey
paper
previous
publish
third
confid
reproduc
agerel
effect
seen
absenc
dietari
challeng
diseas
strengthen
subsequ
observ
relat
microbiom
effect
diet
sbi
intervent
gener
age
male
similar
sexeffect
mt
rate
report
also
impli
causal
chang
mucos
barrier
function
microbiom
model
advantag
lifelong
compar
environ
includ
diet
geographi
social
contact
known
shape
major
microbiom
profil
see
microbiom
chang
stabl
model
mani
month
dietari
consist
known
age
human
transit
physic
nutrit
know
microbiom
manipul
alter
permeabl
data
suggest
microbiom
chang
healthi
age
small
limit
shift
abund
chang
could
result
reduc
immun
surveil
thu
increas
mt
follow
model
suggest
antibiot
approach
preprobiot
approach
known
enhanc
mucu
immun
restor
worthi
pursu
translat
human
health
absenc
detect
shift
microbiom
profil
age
group
across
sampl
site
highlight
effect
diet
environment
consist
profil
allow
us
specul
mucos
pathogen
load
rather
chang
commun
composit
key
chang
age
gut
sbi
outcom
clinic
relev
cheap
readili
avail
intervent
util
enteropathi
immun
compon
conclus
age
gi
still
rel
unknown
landscap
provid
data
primat
gi
system
age
without
dietari
comorbid
diseas
treatment
effect
lead
reduc
barrier
function
mucosa
age
gi
may
make
old
primat
less
resili
challeng
poor
diet
qualiti
translat
relev
studi
shape
futur
investig
improv
barrier
function
dissemin
neg
find
sbi
studi
subject
sourc
multigener
pedigre
coloni
vervet
monkey
chlorocebu
aethiop
sabeu
n
year
lifespan
year
descend
founder
monkey
wake
forest
vervet
research
coloni
femal
hous
within
natal
social
group
durat
natur
determin
due
natur
breed
coloni
age
male
retain
studi
popul
femal
femal
classifi
either
young
old
year
evalu
seri
studi
depict
fig
anim
colon
survey
studi
studi
fed
commerci
laboratori
primat
chow
laboratori
diet
labdiet
st
loui
mo
daili
supplement
fresh
fruit
veget
standard
laboratori
diet
compris
calori
fat
calori
carbohydr
calori
protein
supplementari
tabl
anim
hous
larg
indooroutdoor
enclosur
provid
elev
perch
climb
structur
within
multigener
social
group
ad
libitum
opportun
social
eat
exercis
diet
consumpt
pattern
evalu
repres
select
young
old
monkey
coloni
measur
diet
fed
diet
remain
hour
measur
avail
averag
differ
day
rang
consumpt
measuresmonkey
blood
tissu
sampl
collect
studi
schedul
euthanasia
time
point
differ
studi
anaesthesia
achiev
sodium
pentobarbit
blood
termin
collect
vena
cava
separ
select
old
young
monkey
coloni
challeng
western
diet
studi
supplementari
tabl
western
diet
compris
total
calori
suppli
fat
satur
fat
carbohydr
total
calori
suppli
simpl
sugar
total
calor
densiti
protein
content
compar
chow
diet
calori
howev
protein
sourc
predominantli
anim
sourc
dietari
fibr
compar
diet
approxim
recommend
human
consumpt
level
gday
assess
perform
prediet
postdiet
initi
week
time
point
old
monkey
continu
western
diet
evalu
effect
sbi
supplement
studi
old
monkey
n
given
placebo
gday
sbi
daili
ad
g
daili
food
allot
week
crossov
studi
week
washout
treatment
period
dose
durat
result
improv
mt
paramet
anim
sbi
product
use
entera
health
inc
cari
nc
medic
food
product
avail
prescript
treatment
sever
inflammatori
bowel
diseas
hivassoci
enteropathi
dose
chosen
deliv
paediatr
dose
gd
allow
wast
dose
food
consum
fulli
addit
food
offer
monkey
daili
observ
made
monkey
compliant
consum
sbi
dose
blood
sampl
collect
end
treatment
period
one
anim
euthan
monkey
assess
placebo
monkey
assess
sbi
treatment
euthanasia
occur
washout
period
follow
sbi
therapi
necessit
due
diagnosi
sever
pancreat
pancreat
confirm
diagnost
patholog
tissu
collect
necropsi
anim
procedur
perform
protocol
approv
wake
forest
univers
institut
anim
care
use
committe
accord
recommend
guid
care
use
laboratori
anim
institut
laboratori
anim
research
complianc
usda
anim
welfar
act
anim
welfar
regul
anim
welfar
act
amend
anim
welfar
regul
anim
fast
overnight
anesthet
intramuscular
ketamin
mgkg
allow
sampl
data
collect
studi
anim
weigh
waist
circumfer
measur
flexibl
tape
measur
level
umbilicu
blood
sampl
obtain
venipunctur
femor
vein
ethylenediaminetetraacet
acid
edta
serum
separ
blood
tube
edta
anticoagul
blood
held
ice
could
process
process
plasma
whole
blood
sampl
store
analysi
gener
metabol
health
biochemistri
panel
measur
previous
portal
vein
endotoxin
level
measur
sampl
collect
studi
coincid
colon
tissu
measur
kinet
chromogen
lal
assay
lonza
group
ltd
walkersvil
md
result
character
high
euml
low
endotoxin
level
studi
biomark
mt
use
plasma
concentr
lipopolysaccharid
bind
protein
solubl
measur
elisa
previous
innat
immun
respons
mt
estim
elisa
detect
circulatori
level
secretori
iga
antimicrobi
peptid
primarili
sourc
gut
paneth
cell
ebiosci
vienna
austria
mybiosourc
inc
san
diego
ca
includ
liver
enzym
alanin
aminotransferas
alkalin
phosphatas
alt
alp
studi
portal
deliveri
endotoxin
known
initi
hepat
damag
monkey
within
full
thick
section
collect
midpoint
cecum
transvers
colon
ascend
colon
collect
euthanasia
monkey
studi
colon
tissu
formalin
fix
paraffinembed
prior
section
stain
hematoxylin
eosin
mucu
content
estim
costain
alcian
blue
period
acid
schiff
stain
total
proteoglycan
content
initi
observ
qualiti
blind
observ
measur
crypt
depth
number
goblet
cell
along
intact
villi
goblet
cell
express
number
per
micron
mucu
content
estim
outlin
crypt
intact
villi
region
interest
analys
percent
area
stain
bluepurpl
use
imag
softwar
supplementari
fig
visiopharm
broomfield
co
thick
musculari
layer
measur
transect
widest
point
immunohistochem
stain
tight
junction
protein
occludin
evalu
color
pixil
quantit
imag
softwar
express
averag
area
occludin
imag
pro
plu
version
media
cybernet
score
stain
intens
antibodi
occludin
sourc
abcam
cambridg
santa
cruz
biotechnolog
dalla
tx
respect
immunostain
protocol
previous
exampl
imag
shown
supplementari
fig
sampl
monkey
includ
studi
collect
microbiom
character
fece
colon
lumen
content
mucos
scrape
region
ascend
colon
collect
monkey
use
materi
dna
extract
dna
quantit
sequenc
commerci
laboratori
hudsonalpha
institut
biotechnolog
huntsvil
al
briefli
dna
extract
tissu
sampl
qiagen
qualiti
dna
determin
gel
electrophoresi
amplifi
dna
sequenc
illumina
miseq
sequenc
avail
sra
via
access
mucosallysourc
dna
total
bacteri
gene
content
estim
duplic
pcr
normal
tissu
weight
use
start
old
monkey
variabl
abund
mucosa
howev
valu
includ
outlier
retain
dataset
review
laboratori
process
data
support
valu
real
taxonom
assign
rrna
sequenc
perform
use
rdp
classifi
version
default
paramet
confid
score
addit
taxonom
classif
use
qiim
version
closedrefer
oper
taxonom
unit
otu
pick
default
paramet
green
gene
databas
version
ident
test
consist
classif
method
result
count
tabl
log
normal
previous
ordin
princip
coordin
analysi
perform
use
braycurti
dissimilar
via
capscal
function
vegan
r
packag
relat
r
script
publicli
avail
github
http
githubcommcbtbinfintestinalag
statist
model
r
made
respons
variabl
log
normal
bacteri
abund
sampl
shannon
divers
repres
withinsampl
alphadivers
ordin
axe
repres
betweensampl
betadivers
respons
variabl
investig
three
sampl
type
fece
lumen
mucosa
well
pool
tissu
type
togeth
mix
linear
model
mix
linear
model
nest
sampl
type
within
associ
anim
use
lme
function
r
packag
nlme
addit
explanatori
variabl
agegroup
sampl
sequenc
depth
addit
model
consist
nonparametr
wilcoxon
test
anim
split
old
young
statu
sampl
type
simpl
linear
model
explanatori
variabl
agegroup
sampl
sequenc
depth
sampl
type
benjaminihochberg
method
multipl
hypothesi
correct
use
fals
discoveri
rate
set
detail
set
microbiom
tabl
graph
analys
avail
supplementari
data
file
data
present
mean
sem
group
group
size
measur
indic
figur
tabl
data
analyz
normal
logarithm
transform
necessari
c
ova
adjust
baselin
valu
avail
studi
perform
assess
group
differ
differ
proport
studi
endotoxin
level
analyz
fisher
exact
test
studi
crossov
design
repeat
measur
anova
use
time
treatment
sequenc
baselin
valu
use
statist
model
post
hoc
determin
group
differ
done
use
tukey
honestli
signific
differ
test
pairwis
associ
variabl
evalu
use
pearson
correl
coeffici
normal
distribut
statist
analysi
perform
statistica
softwar
statsoft
inc
tulsa
ok
signific
set
group
differ
trend
